Two publications from the past week:

• Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study | link
• Economic evaluation in psychiatric pharmacogenomics: a systematic review | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

One publication from the past week:

• Clinical utility of whole-genome sequencing in precision oncology | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Two publications from the past week:

• Clinical and cost outcomes following genomics-informed treatment for advanced cancers | link
• Out-of-pocket and private pay in clinical genetic testing: A scoping review | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Two publications from the past week:

• Cost or price of sequencing? Implications for economic evaluations in genomic medicine | link
• Determining Cost-Optimal Next-Generation Sequencing Panels for Rare Disease and Pharmacogenomics Testing | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Five publications from the past week:

• Genomic sequencing for the diagnosis of childhood mitochondrial disorders: a health economic evaluation | link
• A Systematic Review of Discrete Choice Experiments and Conjoint Analysis on Genetic Testing | link
• Project Baby Bear: Rapid precision care incorporating rWGS in 5 California children’s hospitals demonstrates improved clinical outcomes and reduced costs of care | link
• Understanding decisions to participate in genomic medicine in children’s cancer care: A comparison of what influences parents, health care providers, and the general community | link
• Diagnostic Yield and Cost-Effectiveness of “Dynamic” Exome Analysis in Epilepsy with Neurodevelopmental Disorders: A Tertiary-Center Experience in Northern Italy | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

One publication from the past week:

• Diagnosing newborns with suspected mitochondrial disorders: an economic evaluation comparing early exome sequencing to current typical care | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

One publication from the past week:

• Developing new frameworks to value genomic information: accounting for complexity | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

One publication from the past week:

• Early technology assessment of using whole genome sequencing in personalised oncology | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Two publications from the past week:

• Toward the diagnosis of rare childhood genetic diseases: what do parents value most? | link
• Rapid whole genome sequencing impacts care and resource utilization in infants with congenital heart disease | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Two publications from the past week:

• Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine | link
• Micro-costing diagnostics in oncology: from single-gene testing to whole genome sequencing | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.